HomeCompareOCDX vs PEP

OCDX vs PEP: Dividend Comparison 2026

OCDX yields 11.34% · PEP yields 3.63%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PEP wins by $99.6K in total portfolio value· pulled ahead in Year 7
10 years
OCDX
OCDX
● Live price
11.34%
Share price
$17.63
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$42.3K
Annual income
$2,306.36
Full OCDX calculator →
PEP
PepsiCo Inc.
● Live price
3.63%
Share price
$156.82
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$141.9K
Annual income
$61,875.67
Full PEP calculator →

Portfolio growth — OCDX vs PEP

📍 PEP pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOCDXPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OCDX + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OCDX pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OCDX
Annual income on $10K today (after 15% tax)
$964.27/yr
After 10yr DRIP, annual income (after tax)
$1,960.41/yr
PEP
Annual income on $10K today (after 15% tax)
$308.41/yr
After 10yr DRIP, annual income (after tax)
$52,594.32/yr
At 15% tax rate, PEP beats the other by $50,633.91/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OCDX + PEP for your $10,000?

OCDX: 50%PEP: 50%
100% PEP50/50100% OCDX
Portfolio after 10yr
$92.1K
Annual income
$32,091.02/yr
Blended yield
34.84%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

OCDX
No analyst data
PEP
Analyst Ratings
1
Strong
15
Buy
27
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+10.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OCDX buys
0
PEP buys
0
No recent congressional trades found for OCDX or PEP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOCDXPEP
Forward yield11.34%3.63%
Annual dividend / share$2.00$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$42.3K$141.9K
Annual income after 10y$2,306.36$61,875.67
Total dividends collected$17.1K$123.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: OCDX vs PEP ($10,000, DRIP)

YearOCDX PortfolioOCDX Income/yrPEP PortfolioPEP Income/yrGap
1$11,834$1,134.43$10,849$509.42+$985.00OCDX
2$13,918$1,254.70$11,969$750.47+$1.9KOCDX
3$16,271$1,379.03$13,500$1,124.14+$2.8KOCDX
4$18,916$1,506.73$15,680$1,721.66+$3.2KOCDX
5$21,878$1,637.13$18,929$2,715.34+$2.9KOCDX
6$25,179$1,769.55$24,023$4,450.80+$1.2KOCDX
7← crossover$28,845$1,903.31$32,510$7,669.92$3.7KPEP
8$32,901$2,037.77$47,709$14,093.60$14.8KPEP
9$37,377$2,172.31$77,415$28,083.48$40.0KPEP
10$42,300$2,306.36$141,922$61,875.67$99.6KPEP

OCDX vs PEP: Complete Analysis 2026

OCDXStock

Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company is also involved in the provision of contract manufacturing and orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. Ortho Clinical Diagnostics Holdings plc was founded in 1939 and is headquartered in Raritan, New Jersey.

Full OCDX Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this OCDX vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OCDX vs SCHDOCDX vs JEPIOCDX vs OOCDX vs KOOCDX vs MAINOCDX vs MOOCDX vs PMOCDX vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.